<DOC>
	<DOCNO>NCT01019642</DOCNO>
	<brief_summary>Randomized , double blind , placebo-controlled clinical trial vitamin D supplementation ( cholecalciferol , 4,000 IU/day 6 month , 104 postmenopausal woman type 2 diabetes mellitus . The objective evaluate effect vitamin D supplementation C-reactive protein ( CRP ) insulin resistance woman type 2 diabetes mellitus ( T2DM ) . The trial conduct March October 2008 Hospital Mexican Social Security Cuernavaca , Mexico .</brief_summary>
	<brief_title>Vitamin D , C-reactive Protein Insulin Resistance</brief_title>
	<detailed_description>Methods . Randomized , double blind , placebo-controlled clinical trial . We select 104 postmenopausal woman , age 45 65 , uncomplicated T2DM BMI ≥25 . Women history kidney liver disease , BMI &gt; 40 , autoimmune disease cancer include study . Participants randomly assign receive either capsule contain 4,000 IU vitamin D3 ( cholecalciferol , n=52 ) placebo ( n=52 ) , day 6 month . Outcome variables serum CRP , measure high-sensitivity assay ( nephelometry ) , HOMA-IR . Serum vitamin D ( 25-OH-D ) measure HPLC . Outcome variable measure baseline , 3 6 month thereafter . All participant receive diet physical activity counseling , visit clinic medical check-up month . Baseline Results . Mean age 56.8 ± 5.1 y. Baseline BMI 30.7 ± 3.9 . Median CRP concentration 5.0 mg/L ( Interquartile range : 1.0 , 8.5 ) . HOMA index baseline 7.13 ± 3.8 . Serum 25-OH-D concentration baseline 54.5 ± 15.7 nmol/L ( ~22 ng/mL ) . Almost 94 % patient baseline serum 25-OH-D level &lt; 80 nmol/L , 25 % 40 nmol/L . No one level &lt; 20 nmol/L . There statistical difference important variable treatment group onset study .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Type 2 diabetes mellitus w/ &lt; 10 yrs diagnosis Postmenopausal Overweight obesity ( BMI &gt; =25 ) Treated metformin BMI &gt; =40 Liver kidney disease Other important chronic disease : i.e . cancer , autoimmune . Receiving insulin</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>diabetes</keyword>
	<keyword>C-reactive protein</keyword>
	<keyword>insulin resistance</keyword>
</DOC>